Precision Diabetes
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2474 Walnut St 168, Cary, North Carolina...Phone Number
(919) 390-1391Website
www.precisiondiabetesinc.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
2
About Precision Diabetes
Precision Diabetes Inc. is an emerging leader in precision medicine for diabetes, specializing in novel biomarkers and algorithms. The company is the exclusive supplier of the GlycoMark test, which is FDA-cleared and CE-Marked for detecting recent hyperglycemia and glycemic variability across multiple regions including the U.S. and Europe. Their product portfolio also includes partnerships for distributing genetic tests for type 2 diabetes and gestational diabetes. Precision Diabetes aims to revolutionize diabetes diagnostics by offering a range of unique tests that assess the risk and complications associated with diabetes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Precision Diabetes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Precision Diabetes recently announced quarterly report
Check out if Precision Diabetes is spiking on competitors!
Check if Precision Diabetes has recently received funding, and reach out quickly before it becomes old news!
Precision Diabetes, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Precision Diabetes had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Precision Diabetes launches new products
Funding: Get notified immidiatlly once Precision Diabetes has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Precision Diabetes
Recommended Actions
Find VP level buyers at Precision Diabetes
Find 2 more new buyers
Compare Similar Companies to Precision Diabetes
Compare insights from companies similar to Precision Diabetes, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Precision Diabetes
<$5M
11-50
Private
-
2020
N/A
Company Profile Activity
Activity Insights
Precision Diabetes is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Precision Diabetes is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Precision Diabetes.
Precision Diabetes Tech Stack
A closer look at the technologies used by Precision Diabetes
See more technologies
Precision Diabetes News & Media
A New Study Shows GlycoMark is a Novel Biomarker of SGLT-2i Adherence
RALEIGH, N.C., Jan. 10, 2024 /PRNewswire/ -- A new study, "1,5-Anhydroglucitol: A Novel Biomarker of Adherence in Sodium -Glucose Cotransporter 2 Inhibitors," was published online on December 13, 2023, in Diabetes Care, a journal from the American Diabetes Association. The study was...New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance
RALEIGH, N.C., Oct. 30, 2023 /PRNewswire/ -- Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures 1,5-anhydroglucitol, may be useful for evaluating short-term effectiveness and assessing patient compliance of SGLT-2 inhibitor diabetes...New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop
RALEIGH, N.C., Feb. 21, 2023 /PRNewswire/ -- A new study indicates that the GlycoMark blood test identifies high-risk, asymptomatic patients with prediabetes, not detected by standard diabetes tests, hemoglobin A1C and glucose – a critical clinical need, as physicians can identify those...DxGen Corp. and Precision Diabetes, Inc. Announce Strategic Partnership to Launch New Diabetes Point-Of-Care Testing Analyzer into the U.S. Market.
RALEIGH, N.C. and SEOUL, Korea, Aug. 22, 2022 /PRNewswire/ -- Precision Diabetes, Inc. and DxGen Corp. are pleased to announce that they have entered in an exclusive agreement in the U.S. to launch Epithod® AutoDx, a fully-automatic point-of-care (POC) analyzer that measures a...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Precision Diabetes
Sign Up For FreeTo access detailed company insights
Precision Diabetes Inc. is an emerging leader in precision medicine for diabetes, specializing in novel biomarkers and algorithms. The company is the exclusive supplier of the GlycoMark test, which is FDA-cleared and CE-Marked for detecting recent hyperglycemia and glycemic variability across multiple regions including the U.S. and Europe. Their pr... Read More
